Abstract
Cardiovascular diseases represent a major issue in terms of morbidity and mortality for dialysis patients. This morbidity is due to the accelerated atherosclerosis observed in these patients. Atherosclerosis is a chronic inflammatory disease characterized by key players such as monocytes, macrophages or oxidized LDLs. Monocytes-macrophages are classified into subsets of polarized cells, with M1 and M2 macrophages considered respectively as pro- and anti-inflammatory.
The monocyte subsets and phenotypes were analyzed by flow cytometry. These data was completed by the quantification of plasma M-CSF, IL-8, CRP, Mox-LDLs, Apo-B and Apo-AI, chloro-tyrosine and homocitrulline concentrations.
The statistical differences and associations between two continuous variables were assessed using the Mann-Whitney U test and Spearman’s correlation coefficient, respectively.
Hemodialyzed patients showed a significant increase in the concentrations of CRP, M-CSF and IL-8 (inflammation biomarkers) as well as of chloro-tyrosine and homocitrulline (myeloperoxidase-associated oxidative stress biomarkers). Moreover we observed a higher percentage of M2 monocytes in the plasma of hemodialysis patients, as compared to the controls.
Our data suggests that an oxidative stress and an inflammatory environment, amplified in hemodialysis patients, seems to favor an increase in the concentration of circulating M-CSF, therefore leading to an increase of M2 polarization among circulating monocytes.
Short summary Our data suggests that an oxidative stress and an inflammatory environment, amplified in hemodialysis patients, seems to favor an increase in the concentration of circulating M-CSF, associated with an increase of circulating M2 polarized monocytes.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
It is not an interventional study
Funding Statement
VP was supported by the FRIA (Brussels, Belgium) and the UNamur. This study was in part supported by the scientific commission of CHU-Charleroi. The Analytical Platform of the Faculty of Pharmacy, with the ESI-triple quadrupole mass spectrometer (PVA) was supported by the FNRS.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Valérie Pireaux, URBC-Narilis, University of Namur, 61 rue de Bruxelles, 5000 Namur, Belgium, valerie.pireaux{at}unamur.be, Tel.: +32 81 72 41 29
Cédric Delporte, Laboratory of Pharmaceutical Chemistry and Analytical Platform of the Faculty of Pharmacy, ULB (Campus de la Plaine) CP205/05, Boulevard du Triomphe, Brussels, Belgium, cedric.delporte{at}ulb.ac.be, Tel.: +32 26 50 52 77
Alexandre Rousseau, Laboratory of Experimental Medicine (ULB 222 Unit), Université Libre de Bruxelles, CHU-Charleroi, ISPPC Hôpital Vésale, Montigny-Le-Tilleul, Belgium, alexandre.rousseau{at}chu-charleroi.be, Tel.: +32 81 92 47 17
Jean-Marc Desmet, Nephrology-Hemodialysis Unit, CHU-Charleroi, ISPPC Hôpital Vésale, Montigny-Le-Tilleul, Belgium., jeanmarc.desmet{at}chu-charleroi.be, Tel.: +32 71 92 11 31
Pierre Van Antwerpen, Laboratory of Pharmaceutical Chemistry and Analytical Platform of the Faculty of Pharmacy, Université Libre de Bruxelles (Campus de la Plaine) CP205/05, Boulevard du Triomphe, Brussels, Belgium, pierre.van.antwerpen{at}ulb.ac.be, Tel.: +32 26 50 52 63
Martine Raes, URBC-Narilis, University of Namur, 61 rue de Bruxelles, 5000 Namur, Belgium, martine.raes{at}unamur.be, Tel.: +32 81 72 41 24, Fax.: +32 81 72 41 35
Data Availability
All data are available